1. 首页
  2. 产品目录
  3. 精细化学
  4. 通用试剂
  5. 羰基化合物
  6. 酯

乙基 3-(2-(((4-氰基苯基)胺)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-羰氨基)丙酸酯,98%

Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate （订货以CAS编码或英文名称为准）

厂家直销
创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载
编号：PA42225
分子式：C27H26N6O3
CAS号：211915-84-3
分子量：482.53
申请试用
货号 品牌 规格 纯度/含量 标准价 优惠价 库存货期 数量 购买
PA42225-200mg PERFEMIKER 200mg
98%
 ¥33.00 登录后可见
PA42225-1g PERFEMIKER 1g
98%
 ¥107.00 登录后可见
PA42225-5g PERFEMIKER 5g
98%
 ¥271.00 登录后可见
PA42225-25g PERFEMIKER 25g
98%
 ¥905.00 登录后可见
PA42225-100g PERFEMIKER 100g
98%
 ¥3160.00 登录后可见
中文名称： 3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯
中文别名： 3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯;达比加群中间体3;达比加群酯中间体5;N-[[2-[[(4-氰基苯)胺]甲基]-1甲基-1H-5-苯并咪唑]羰基]3-氨基苯酰基]N-2-吡啶基-B-丙氨酸乙酯,抗血栓药 达比加群中间体;N-[[2-[[(4-氰基苯)胺]甲基]-1甲基-1H-5-苯并咪唑]羰基]3-氨基苯酰基]N-2-吡啶基-B-丙氨酸乙酯;乙基 3-(2-(((4-氰基苯基)胺)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-羰氨基)丙酸酯;3-(((2-(((4-氰基苯基)氨基)甲基)-1-甲基-1H-苯并咪唑-5-基)羰基)吡啶-2-基氨基)丙酸乙酯;3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸;3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯 （达比加群酯）;3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯;3-乙炔基-苯硼酸;比加群酯中间体1（84-3）;达比加群杂质I;达比加群酯中间体N-2;甲磺酸达比加群酯;乙基 3-(2-((4-氰基苯基氨基)甲基)-1-甲基-N-(吡啶-2-基)-1 H-苯并[d]咪唑-5-羰基xamido)丙烷oate
英文名称： Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
英文别名： Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido;Dabigatran Intermediate 3;Ethyl 3-(2-((4-cyanophenylaMino)Methyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMi;Ethyl 3-(2-((4-cyanophenylaMino)Methyl)-1-Methyl-N-(pyridin-2-yl)-;3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propi;Ethyl 3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino] propionate;Deacetamidine Cyano Dabigatran Ethyl Ester;3-({2-[(4-Cyano-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ethyl ester;3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester;3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester;DB-6;ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate;N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridi nyl-β-alanine, ethyl ester;1-methyl-2-[N-(4-cyanophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)-amide;1-methyl-2-<2-methylthio-2-(4-methyl-1-piperazino)vinyl>-quinolinium iodide;3-({2-[(4-cyano-phenylamino)methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}pyridin-2-ylamino)propionic acid ethyl ester;ethyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;C27H28N6O3;OZBOESGNDSV;CID 11627749;3-({2-[(4-Cyano-phenylamino)-;Ethyl 3-[[2-[(4-Cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoate;Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate;AMY4165;CS-M2456;MFCD09833627;InChI=1/C27H26N6O3/c1-3-36-26(34)13-15-33(24-6-4-5-14-29-24)27(35)20-9-12-23-22(16-20)31-25(32(23)2)18-30-21-10-7-19(17-28)8-11-21/h4-12,14,16,30H,3,13,15,18H2,1-2H3;211915-84-3;ethyl 3-{[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino}propanoate;AKOS015891389;3-[[[2-[[(4-cyanophenyl) amino]methyl]-1-methyl-1h-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester;Deacetamidine cyano dabigatran ethyl ester;OZBOESGNDSVMDK-UHFFFAOYSA-;3-((2-(((4-cyanophenyl)aminomethyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)pyridin-2-ylamino)propionic acid ethyl ester;A4584;Dabigatran impurity I;FT-0687614;BCP27981;Ethyl 3-[[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionate;3-({2-[(4-cyano-ph...
CAS号： 211915-84-3
分子式： C27H26N6O3
分子量： 482.53
详细描述 博飞美科的乙基 3-(2-(((4-氰基苯基)胺)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-羰氨基)丙酸酯,98%为酯,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为100g。查询关键词:酯，211915-84-3，乙基 3-(2-(((4-氰基苯基)胺)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-羰氨基)丙酸酯,98%，Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-meth
搜索质检报告(COA)
相关产品